Princeton Global Asset Management’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Princeton Global Asset Management’s Portfolio BTCY Stock Details BTCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-834	Closed	-$196	–	695
2024 Q3	$196	Hold	834	–	–	﹤0.01%	655
2024 Q2	$750	Hold	834	–	–	﹤0.01%	638
2024 Q1	$1.23K	Hold	834	–	–	﹤0.01%	552
2023 Q4	$959	Hold	834	–	–	﹤0.01%	601
2023 Q3	$1.78K	Buy	834 +1	+0.1%	+$2	﹤0.01%	523
2023 Q2	$3.19K	Hold	833	–	–	﹤0.01%	493
2023 Q1	$2.33K	Buy	+833	New	+$3.42K	﹤0.01%	514

Princeton Global Asset Management's BTCY Position: Q4 2024 in Review

Princeton Global Asset Management sold out of Biotricity, Inc. Common Stock (BTCY) in Q4 2024, closing a stake of 834 shares — an estimated $196 sold.

Princeton Global Asset Management first reported a position in BTCY in Q1 2023 and held it in 7 quarters. The position peaked at $3.19K in Q2 2023. 0 funds tracked by Wall St. Rank hold BTCY as of Q4 2024.

Princeton Global Asset Management reported no remaining Biotricity, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Princeton Global Asset Management sold 834 Biotricity, Inc. Common Stock shares in Q4 2024, an estimated $196.
Princeton Global Asset Management first reported a position in Biotricity, Inc. Common Stock in Q1 2023 and held it in 7 quarters.
Princeton Global Asset Management's Biotricity, Inc. Common Stock position peaked at $3.19K in Q2 2023.
0 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q4 2024.

Based on Princeton Global Asset Management's 13F filing for Q4 2024, filed 24 Jan 2025.